Articles
HollisterStier Laboratories To Lyophilize FDA Approved Sterile Injectable For Bracco Diagnostics Inc.
August 1, 2008
HollisterStier Laboratories announced recently they have signed a manufacturing agreement to fill/finish Bracco Diagnostics Inc.'s approved Choletec® (Kit for the Preparation of Technetium Tc 99m Mebrofenin). For more information, and complete Prescribing Information, please go to: http://www.bracco.com/usa/en-US/Imaging/Nuclear/Choletec/ "HollisterStier looks forward to working with Bracco Diagnostics Inc. as their contract manufacturer of this very important product" said Jeff Milligan, HollisterStier's Vice President of Operations and Business Excellence.
About HollisterStier Contract Manufacturing
HollisterStier Laboratories are experts in the contract manufacture of high-quality sterile injectables for the global pharmaceutical and biopharmaceutical market. Multidisciplinary teams provide custom solutions to customer-specific project goals from development through commercialization. Founded in 1921 and based in Spokane, Washington, HollisterStier is committed to meeting customer expectations in all aspects of business from quality manufacturing to regulatory support.
The company has leading pharmaceutical, generic, and biotechnology companies as its customers. HollisterStier Laboratories LLC is owned by Jubilant Organosys Ltd. For further information about HollisterStier contract manufacturing,visit www.fill.hollisterstier.com and for Jubilant Organosys, www.jubl.com.
About Bracco Imaging
Bracco Imaging S.p.A. is one of the world's leading companies in the diagnostic imaging business. Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs and facilitate clinical solutions. Headquartered in Milan, Italy, Bracco Imaging operates in over 80 markets worldwide. Bracco Diagnostics Inc. is the U.S. subsidiary of Bracco Imaging. A Jubilant Organosys Company Bracco Imaging is a subsidiary of Bracco S.p.A., the holding company of the Bracco Group which also markets Ethical and Over The Counter (OTC) pharmaceutical products in Italy as well as Advanced Medical Technology systems worldwide. Furthermore, the Bracco Group offers diagnosis services through the Milan-based Centro Diagnostico Italiano (Italian Diagnostic Center). For more information, visit www.bracco.com.
